Wellington Management Group LLP Amylyx Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.71 - $19.57 $91,958 - $664,068	33,933 New	33,933 $96,000
Q4 2023 Feb 12, 2024	BUY	$12.07 - $18.46 $540,168 - $826,140	44,753 New	44,753 $658,000
Q2 2023 Aug 14, 2023	SELL	$20.98 - $31.42 $1.9 Million - $2.85 Million	-90,713 Reduced 83.66%	17,716 $382,000
Q1 2023 May 12, 2023	BUY	$27.71 - $40.93 $1.12 Million - $1.66 Million	40,524 Added 59.68%	108,429 $3.18 Million
Q4 2022 Feb 13, 2023	BUY	$29.75 - $39.26 $2.02 Million - $2.67 Million	67,905 New	67,905 $2.51 Million

128

44M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $225M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.